Home›Companies›Healthcare›Nurture Genomics

Nurture Genomics, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 9, 2025·Suggest an edit

About Nurture Genomics

Nurture Genomics is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $4,335,000 raised in one offering on Form D since October 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 23, 2022Oct 5, 2022amended Sep 9, 2025$4,335,000of $6.0M target40$108KEquity, Options, Simple Agreement for Future EquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nurture Genomics's Form D filed Sep 9, 2025.

SB
Steffanie Bristol
Executive officer
RG
Robert Green
Executive Chair
DF
David Feinberg
Executive officer

Sources

  1. SECNurture Genomics, Inc. Form D/A, filed Aug 8, 2023
  2. SECNurture Genomics, Inc. Form D, filed Oct 5, 2022
  3. SECNurture Genomics, Inc. filing history